110.16
前日終値:
$113.37
開ける:
$113.17
24時間の取引高:
849.64K
Relative Volume:
1.25
時価総額:
$11.91B
収益:
$769.10M
当期純損益:
$46.67M
株価収益率:
314.74
EPS:
0.35
ネットキャッシュフロー:
$119.79M
1週間 パフォーマンス:
-9.10%
1か月 パフォーマンス:
-1.48%
6か月 パフォーマンス:
+150.59%
1年 パフォーマンス:
+38.62%
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CORT
Corcept Therapeutics Inc
|
110.16 | 11.91B | 769.10M | 46.67M | 119.79M | 0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-08-18 | 再開されました | Truist | Buy |
| 2026-07-27 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2026-05-13 | アップグレード | UBS | Neutral → Buy |
| 2026-03-26 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | 開始されました | UBS | Neutral |
| 2025-11-18 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-06 | アップグレード | Truist | Hold → Buy |
| 2023-04-11 | 開始されました | SVB Securities | Market Perform |
| 2023-04-04 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-01 | ダウングレード | Truist | Buy → Hold |
| 2022-07-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-06-27 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-02 | 開始されました | Canaccord Genuity | Buy |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-09-24 | 開始されました | Jefferies | Buy |
| 2019-09-06 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 繰り返されました | Stifel | Hold |
| 2018-05-31 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 開始されました | Stifel | Buy |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-04-21 | 開始されました | FBR Capital | Outperform |
| 2014-01-13 | ダウングレード | Stifel | Buy → Hold |
| 2013-08-09 | ダウングレード | Janney | Buy → Neutral |
| 2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains - Zacks Investment Research
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research
FDA Expands ImmunityBio's Anktiva Label in Bladder Cancer - Zacks Investment Research
Here's Why You Should Add EYPT Stock to Your Portfolio Now - Zacks Investment Research
RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week - Zacks Investment Research
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Zacks Investment Research
Here's Why You Should Add ANRO Stock to Your Portfolio Now - Zacks Investment Research
Syndax Stock Falls 16% as Phase II Fibrosis Study Misses Primary Goal - Zacks Investment Research
BMY Reports Mixed Phase III Trial Results, Stock Down - Zacks Investment Research
Are Options Traders Betting on a Big Move in Corcept Therapeutics Stock? - Zacks Investment Research
Drugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case - Reuters
Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why - Zacks Investment Research
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know - Zacks Investment Research
Corcept Therapeutics Inc (HTD.DU) Stock Forum & Discussion - Yahoo! Finance Canada
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Erasca, Inc. (ERAS), DICK’S Sporting Goods, Inc. (DKS), Corcept Therapeutics Incorporated (CORT), and Charter Communications, Inc. (CHTR) - Supply Chain Digital
Piper Sandler Keeps Their Buy Rating on Corcept Therapeutics (CORT) - The Globe and Mail
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Corcept Therapeutics Insider Sold Shares Worth $2,906,601, According to a Recent SEC Filing - Yahoo Finance
Corcept Therapeutics (NasdaqCM:CORT) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 4 Corcept Therapeutics Incorporated For: 5 October By Investing.com - Investing.com India
Form 4 Corcept Therapeutics Incorporated For: 5 October By Investing.com - Investing.com Nigeria
Corcept Therapeutics president Sean Maduck sells $2.9 million in stock By Investing.com - Investing.com Australia
Corcept Therapeutics president Sean Maduck sells $2.9 million in stock - Investing.com
Corcept Therapeutics president sells $967k in shares - Investing.com
Corcept Therapeutics chief accounting officer sells $1.16m - Investing.com
Corcept Therapeutics Oncology President Reports Stock Option Exercise and Sales in Form 4 Filing - Kalkine Media
Corcept Therapeutics' Sean Maduck Executes Stock Option Exercises and Sells Shares Under 10b5-1 Plan - Kalkine Media
100,000 stock options awarded to Corcept (CORT) officer vest over four years, subject to continued service. - Stock Titan
An officer reports 12,191 shares, including unvested awards, and four option positions at Corcept (CORT). - Stock Titan
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies - Zacks Investment Research
Corcept Therapeutics Incorporated (CORT) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies - Yahoo Finance
Corcept Therapeutics Inc. R (HTD.DU) Q1 FY2026 earnings call transcript - Yahoo Finance
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike - Zacks Investment Research
After a $1.13M September sale, Corcept (CORT) officer proposes another share sale. - stocktitan.net
Non-controlling/minority interest of Corcept Therapeutics Incorporated. – HAN:HTD - TradingView
Corcept Therapeutics (CORT) business chief gifts shares; two custodial accounts acquire 5,000 each - stocktitan.net
Form 4 Corcept Therapeutics Incorporated For: 28 September By Investing.com - Investing.com Nigeria
Corcept Therapeutics’ oncology president sells $29,842 in stock - Investing.com
Form 4 Corcept Therapeutics Incorporated For: 28 September By Investing.com - Investing.com Canada
Corcept Therapeutics Inc (CORT) Stock Price, Quote, News & History - Benzinga
Strong Commercial Execution and Pipeline Opportunities Propel Corcept Therapeutics (CORT) - Yahoo Finance
Corcept Therapeutics' Sean Maduck to Resign as President of Corcept Endocrinology, to Serve as Consultant - TradingView
Corcept Therapeutics: Justin Gunn to Succeed Maduck, Assume New Responsibilities Starting Oct 1 >CORT - Moomoo
Corcept Announces Planned Leadership Transition - Business Wire
Corcept Therapeutics (CORT) CHMP Backing Keeps Undervalued Narrative In Focus - finance.yahoo.com
Corcept’s (CORT) Cancer Drug Just Cleared Europe’s Toughest Hurdle - finance.yahoo.com
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer - finance.yahoo.com
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer - Your Wyoming Link
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer - Zacks Investment Research
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
Corcept Therapeutics Inc (CORT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Vieira Roberto Wandenkolk | President, Oncology |
Oct 02 '26 |
Sale |
116.10 |
8,333 |
967,448 |
3,946 |
| Lyon Joseph Douglas | See Remarks |
Oct 02 '26 |
Option Exercise |
17.18 |
9,190 |
157,864 |
14,873 |
| Maduck Sean | See Remarks |
Oct 02 '26 |
Sale |
116.28 |
24,587 |
2,858,884 |
9,938 |
| Maduck Sean | See Remarks |
Oct 02 '26 |
Option Exercise |
8.27 |
24,587 |
203,334 |
34,525 |
| Lyon Joseph Douglas | See Remarks |
Oct 02 '26 |
Sale |
116.13 |
9,190 |
1,067,258 |
5,683 |
| Lyon Joseph Douglas | See Remarks |
Oct 01 '26 |
Option Exercise |
13.56 |
810 |
10,984 |
6,493 |
| Lyon Joseph Douglas | See Remarks |
Oct 01 '26 |
Sale |
115.40 |
810 |
93,473 |
5,683 |
| Maduck Sean | See Remarks |
Oct 01 '26 |
Option Exercise |
8.27 |
413 |
3,416 |
10,351 |
| Lyon Joseph Douglas | Officer |
Oct 01 '26 |
Proposed Sale |
115.23 |
10,000 |
1,152,300 |
0 |
| Maduck Sean | See Remarks |
Oct 01 '26 |
Sale |
115.54 |
413 |
47,717 |
9,938 |
大文字化:
|
ボリューム (24 時間):